Ngā hua rapu - Kate Talks

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
  1. 1
    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival mā Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, Helen Turley, Kate Talks, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B mā Rachel Rayment, Elizabeth Chalmers, Katherine E. Law, Richard Gooding, Anne M. Kelly, Susan Shapiro, Kate Talks, Oliver Tunstall, Tina Biss

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp>

    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp> mā Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael D. Williams, C. R. M. Hay

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Ex... mā Peter W. Collins, Ri Liesner, Michael Makris, Kate Talks, Pratima Chowdary, Elizabeth Chalmers, Georgina Hall, Anne Riddell, Charles Percy, C. R. M. Hay, Daniel P. Hart

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia mā Charlotte Bradbury, Julie Pell, Quentin A. Hill, Catherine Bagot, Nichola Cooper, Jenny Ingram, Katie Breheny, Rebecca Kandiyali, Rachel Rayment, Gillian Evans, Kate Talks, Ian Thomas, Rosemary Greenwood

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α

    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α mā Michael S. Wiesener, Helen Turley, William E. Allen, Carsten Willam, Kai‐Uwe Eckardt, Kate Talks, S.M. Wood, Kevin C. Gatter, Adrian L. Harris, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell

    I whakaputaina 1998
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B mā Pratima Chowdary, Susan Shapiro, Michael Makris, Gillian Evans, Sara Boyce, Kate Talks, Gerard Dolan, Ulrike M. Reiss, Mark Phillips, Anne Riddell, Maria R. Peralta, Michelle Quaye, David Patch, Edward G. D. Tuddenham, Allison Dane, Marie Watissée, Alison Long, Amit C. Nathwani

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study

    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study mā Nichola Cooper, Marie Scully, Charles Percy, Phillip L. R. Nicolson, Gillian Lowe, Catherine Bagot, Jecko Thachil, H. Grech, Tim Nokes, Quentin A. Hill, Charlotte Bradbury, Kate Talks, Tina Dutt, Gillian Evans, Sue Pavord, Sarah Wexler, Asad Charania, Sarah J. Collington, Andrew Ervin, Nicholas Ramscar, Drew Provan

    I whakaputaina 2024
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: